Chongqing EVAHEART Medical Device Co., Ltd. announced that it has received $100 million in series A round of funding led by new investor Sinovac Biotech Co., Ltd. on March 9, 2023. The transaction also included participation from new investor China Taiping Insurance Holdings Company Limited, returning investor Vivo Capital, LLC.